FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy
Kazandjian, D., Suzman, D. L., Blumenthal, G., Mushti, S., He, K., Libeg, M., Keegan, P., Pazdur, R.Language:
english
Journal:
The Oncologist
DOI:
10.1634/theoncologist.2015-0507
Date:
March, 2016
File:
PDF, 1.27 MB
english, 2016